{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:06:39Z","timestamp":1747181199684,"version":"3.40.5"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,23]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Methimazole (MMI) is the first-line agent in the treatment of hyperthyroidism. However, rare but severe cholestatic jaundice may occur. Therapeutic plasma exchange (TPE) may provide an alternative treatment for such patients and they received thyroidectomy\/radioactive iodine ablation or continued oral anti hyperthyroidism medication immediately after TPE session in the reported literatures. The case reported here is, to our knowledge, the first to describe the long interval between anti hyperthyroidism therapy and TPE in such patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 49-year-old Chinese woman had developed worsening jaundice 3 weeks after receiving methimazole (20\u2009mg\/day) for the treatment of hyperthyroidism secondary to Graves\u2019 disease (GD). Additionally, she had a 2-year history of type 2 diabetes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Hyperthyroidism secondary to GD, MMI-induced severe cholestatic jaundice and type 2 diabetes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Methimazole was discontinued and the patient received 3 times of TPE, about 3-month glucocorticoid treatment, insulin administration accordingly and other conventional liver-protecting therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Her thyroid function was stabilized with small dose of thyroxine substitution and euthyroid status persisted after thyroxine discontinuation until hyperthyroidism recurred 7 months later while her cholestatic jaundice was eventually recovered by about 3-month glucocorticoid therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Due to the complex interplay between liver function and thyroid hormones, there may be unusual changes of thyroid function in GD patients with severe liver injury after TPE. By this case, we want to highlight the importance of a closely following up of thyroid function in order to deliver appropriate health suggestions for patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037074","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T21:05:01Z","timestamp":1708722301000},"page":"e37074","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["An unusual evolution of thyroid function after therapeutic plasma exchange in Graves\u2019 disease with cholestatic jaundice: A case report"],"prefix":"10.1097","volume":"103","author":[{"given":"Yamei","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6446-9873","authenticated-orcid":false,"given":"Xiaohong","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixiang","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1021\/acs.chemrestox.1c00300","article-title":"Role of CYP2A6 in methimazole bioactivation and hepatotoxicity.","volume":"34","author":"Li","year":"2021","journal-title":"Chem Res Toxicol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"e00526","DOI":"10.14309\/crj.0000000000000526","article-title":"Cholestatic hepatitis in graves\u2019 disease: a diagnostic challenge.","volume":"8","author":"Haddaden","year":"2021","journal-title":"ACG Case Rep J"},{"key":"R3-20250503","first-page":"86","article-title":"Therapeutic plasma exchange in refractory hyperthyroidism.","volume":"10","author":"Saie","year":"2021","journal-title":"Eur Thyroid J"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.1970.03180070041007","article-title":"Thyroid storm treatment with blood exchange and plasmapheresis.","volume":"214","author":"Ashkar","year":"1970","journal-title":"JAMA"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"102826","DOI":"10.1016\/j.transci.2020.102826","article-title":"Preoperative plasmapheresis experience in Graves\u2019 disease patients with anti-thyroid drug-induced hepatotoxicity.","volume":"59","author":"Apaydin","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"102677","DOI":"10.1016\/j.transci.2019.102677","article-title":"Role of high-volume plasma exchange in a case of a G6PD deficient patient presenting with HAV related acute liver failure and concomitant acute renal failure.","volume":"58","author":"Bajpai","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"R8-20250503","first-page":"e8721","article-title":"The use of high volume plasmapheresis in acute liver failure.","volume":"12","author":"Tam","year":"2020","journal-title":"Cureus"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"725559","DOI":"10.3389\/fendo.2021.725559","article-title":"Crash landing of thyroid storm: a case report and review of the role of extra-corporeal systems.","volume":"12","author":"Lim","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1089\/thy.2019.0045","article-title":"Analysis of antithyroid drug-induced severe liver injury in 18,558 newly diagnosed patients with graves\u2019 disease in Japan.","volume":"29","author":"Suzuki","year":"2019","journal-title":"Thyroid"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"200","DOI":"10.14218\/JCTH.2020.00009","article-title":"Herb-induced liver injury in asia and current role of RUCAM for causality assessment in 11,160 published cases.","volume":"8","author":"Teschke","year":"2020","journal-title":"J Clin Transl Hepatol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12876-022-02133-z","article-title":"Graves\u2019 disease overlapping with chronic hepatitis B and methimazole-induced liver injury and autoimmune hepatitis: a case report.","volume":"22","author":"Zheng","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s40618-020-01208-6","article-title":"The interplay between thyroid and liver: implications for clinical practice.","volume":"43","author":"Piantanida","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/JOE-15-0133","article-title":"The molecular basis of the non-thyroidal illness syndrome.","volume":"225","author":"de Vries","year":"2015","journal-title":"J Endocrinol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-8587(15)00225-9","article-title":"Thyroid function in critically ill patients.","volume":"3","author":"Fliers","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ageing\/afp197","article-title":"Non-thyroidal illness syndrome and short-term survival in a hospitalised older population.","volume":"39","author":"Tognini","year":"2010","journal-title":"Age Ageing"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"e210504","DOI":"10.1530\/EC-21-0504","article-title":"Non-thyroidal illness syndrome predicts outcome in adult critically ill patients: a systematic review and meta-analysis.","volume":"11","author":"Vidart","year":"2022","journal-title":"Endocr Connect"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12902-021-00896-2","article-title":"Suppression of the hypothalamic\u2013pituitary\u2013thyroid axis is associated with the severity of prognosis in hospitalized patients with COVID-19.","volume":"21","author":"Zheng","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"850328","DOI":"10.3389\/fendo.2022.850328","article-title":"Nonthyroidal illness syndrome: to treat or not to treat? Have we answered the question? A review of metanalyses.","volume":"13","author":"Sciacchitano","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"939842","DOI":"10.3389\/fendo.2022.939842","article-title":"Thyroid function, inflammatory response, and glucocorticoids in COVID-19.","volume":"13","author":"Swiatkowska-Stodulska","year":"2022","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:32:08Z","timestamp":1746318728000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037074","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}